NCT06587451 2026-02-24
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
Sandoz
Phase 3 Terminated
Clinical Trials
9 trialsNCT00651326 2023-08-04
DART
Canadian Cancer Trials Group
Phase 3 Terminated
NCT02532400 2020-03-11
COMPETE
Ruijin Hospital
Phase 3 Terminated
NCT01314027 2019-07-25
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
University of Zurich
Phase 3 Terminated
NCT00574080 2017-11-20
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
University of Arkansas
Phase 3 Terminated
NCT00190528 2016-09-22
A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer
Japan Clinical Oncology Group
Phase 3 Terminated
NCT00113386 2013-06-28
Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 3 Terminated
NCT00004099 2012-09-24
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00559351 2007-11-16
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
Ministry of Scientific Research and Information Technology, Poland
Phase 3 Terminated